↓ Skip to main content
What is this page? Embed badge

Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American…

Overview of attention for article published in Journal of Clinical Oncology, May 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
9 news outlets
blogs
1 blog
twitter
23 X users
patent
1 patent
googleplus
1 Google+ user
guideline
2 clinical guideline sources

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
Published in
Journal of Clinical Oncology, May 2017
DOI 10.1200/jco.2015.66.2510
Pubmed ID
28486043
Authors

Mikkael A Sekeres, Megan Othus, Alan F List, Olatoyosi Odenike, Richard M Stone, Steven D Gore, Mark R Litzow, Rena Buckstein, Min Fang, Diane Roulston, Clara D Bloomfield, Anna Moseley, Aziz Nazha, Yanming Zhang, Mario R Velasco, Rakesh Gaur, Ehab Atallah, Eyal C Attar, Elina K Cook, Alyssa H Cull, Michael J Rauh, Frederick R Appelbaum, Harry P Erba

View on publisher site

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 113 99%

Demographic breakdown

Readers by professional status Count As %
Other 12 11%
Student > Bachelor 11 10%
Researcher 9 8%
Student > Doctoral Student 6 5%
Student > Ph. D. Student 6 5%
Other 23 20%
Unknown 47 41%
Readers by discipline Count As %
Medicine and Dentistry 37 32%
Biochemistry, Genetics and Molecular Biology 14 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Nursing and Health Professions 4 4%
Agricultural and Biological Sciences 3 3%
Other 3 3%
Unknown 49 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 98. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2025.
All research outputs
#511,665
of 29,656,302 outputs
Outputs from Journal of Clinical Oncology
#1,085
of 27,524 outputs
Outputs of similar age
#9,029
of 336,005 outputs
Outputs of similar age from Journal of Clinical Oncology
#28
of 546 outputs
Altmetric has tracked 29,656,302 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 27,524 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 336,005 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 546 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.